No treatment |
Visual signs of BRD, rectal temperature <40°C and CALA score <2 |
No treatment |
First treatment-less severe BRD, <60 DOF |
Visual signs and CALA score 2, or no visual signs and CALA score 2, or visual signs and rectal temperature ≥40°C, or no visual signs and rectal temperature ≥40°C |
Tilmicosin (Micotil, Elanco Animal Healthy, West Ryde, Australia) |
First treatment-severe BRD, <60 DOF |
CALA score 3 with or without visual signs, or rectal temperature ≥ 40°C and CALA score ≥2 with or without visual signs |
Tulathromycin (Draxxin, Zoetis Animal Health, NJ, USA) |
Second treatment |
Pulled for BRD a second time or received Tulathromycin for the first BRD treatment |
Oxytetracycline (Engemycin, MSD Animal Health, Wellington, New Zealand) |
Third treatment |
Pulled for BRD a third time |
Florfenicol (Nuflor, Merck Animal Health, Madison, NJ, USA) and Meloxicam (Troy Laboratories, Glendenning, Australia) |
First treatment ≥60 DOF, or fourth BRD treatment |
Treated regardless of rectal temperature of CALA score, or pulled for BRD a fourth time |
Ceftiofur (Excede, Zoetis Animal Health, Lincoln, NE, USA) |